GENPHAR INC has a total of 19 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Australia, United States and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are COLD GENESYS INC, TAKEDA VACCINES INC and NABEL GARY J.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | United States | 3 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | South Africa | 2 | |
#8 | Hong Kong | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Climate change adaptation technologies | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Wang Danher | 16 |
#2 | Dong Jianyun | 2 |
#3 | Danher Wang | 2 |
#4 | Wang Dancher | 1 |
Publication | Filing date | Title |
---|---|---|
AU2008203228A1 | Genphar, Inc. | |
AU2007203565A1 | Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens | |
KR20050042458A | Genetic vaccine against human immunodeficiency virus | |
US7754201B2 | Method of vaccination through serotype rotation | |
US6544780B1 | Adenovirus vector with multiple expression cassettes |